Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2004 1
2005 1
2006 2
2007 2
2008 2
2009 5
2010 4
2011 3
2012 2
2014 5
2015 3
2016 2
2018 1
2019 6
2020 5
2021 6
2022 14
2023 7
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

69 results

Results by year

Filters applied: . Clear all
Page 1
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial.
Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Riesmeyer JS, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators. Gerstein HC, et al. Lancet. 2019 Jul 13;394(10193):121-130. doi: 10.1016/S0140-6736(19)31149-3. Epub 2019 Jun 9. Lancet. 2019. PMID: 31189511 Clinical Trial.
Diet Advice for Crohn's Disease: FODMAP and Beyond.
Popa SL, Pop C, Dumitrascu DL. Popa SL, et al. Among authors: pop c. Nutrients. 2020 Dec 6;12(12):3751. doi: 10.3390/nu12123751. Nutrients. 2020. PMID: 33291329 Free PMC article. Review.
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial.
Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Botros FT, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators. Gerstein HC, et al. Lancet. 2019 Jul 13;394(10193):131-138. doi: 10.1016/S0140-6736(19)31150-X. Epub 2019 Jun 9. Lancet. 2019. PMID: 31189509 Clinical Trial.
Deep Learning and Antibiotic Resistance.
Popa SL, Pop C, Dita MO, Brata VD, Bolchis R, Czako Z, Saadani MM, Ismaiel A, Dumitrascu DI, Grad S, David L, Cismaru G, Padureanu AM. Popa SL, et al. Among authors: pop c. Antibiotics (Basel). 2022 Nov 21;11(11):1674. doi: 10.3390/antibiotics11111674. Antibiotics (Basel). 2022. PMID: 36421316 Free PMC article. Review.
Artificial Intelligence and Antibiotic Discovery.
David L, Brata AM, Mogosan C, Pop C, Czako Z, Muresan L, Ismaiel A, Dumitrascu DI, Leucuta DC, Stanculete MF, Iaru I, Popa SL. David L, et al. Among authors: pop c. Antibiotics (Basel). 2021 Nov 10;10(11):1376. doi: 10.3390/antibiotics10111376. Antibiotics (Basel). 2021. PMID: 34827314 Free PMC article. Review.
Diagnosis of Liver Fibrosis Using Artificial Intelligence: A Systematic Review.
Popa SL, Ismaiel A, Abenavoli L, Padureanu AM, Dita MO, Bolchis R, Munteanu MA, Brata VD, Pop C, Bosneag A, Dumitrascu DI, Barsan M, David L. Popa SL, et al. Among authors: pop c. Medicina (Kaunas). 2023 May 21;59(5):992. doi: 10.3390/medicina59050992. Medicina (Kaunas). 2023. PMID: 37241224 Free PMC article. Review.
Exclusion Diets in Functional Dyspepsia.
Popa SL, Dumitrascu DI, Pop C, Surdea-Blaga T, Ismaiel A, Chiarioni G, Dumitrascu DL, Brata VD, Grad S. Popa SL, et al. Among authors: pop c. Nutrients. 2022 May 14;14(10):2057. doi: 10.3390/nu14102057. Nutrients. 2022. PMID: 35631198 Free PMC article.
Life-threatening complications of hyperemesis gravidarum.
Popa SL, Barsan M, Caziuc A, Pop C, Muresan L, Popa LC, Perju-Dumbrava L. Popa SL, et al. Among authors: pop c. Exp Ther Med. 2021 Jun;21(6):642. doi: 10.3892/etm.2021.10074. Epub 2021 Apr 16. Exp Ther Med. 2021. PMID: 33968173 Free PMC article.
69 results